Treace Medical Concepts (TMCI) Return on Capital Employed (2021 - 2026)
Treace Medical Concepts' (TMCI) quarterly Return on Capital Employed came in at 36.47% in Q1 2026, down 713.0% YoY from 5.95% in Q1 2025, and down 9.73% on a QoQ basis from 33.23% in Q4 2025.
Treace Medical Concepts (TMCI) Return on Capital Employed (2021 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 6 years of Return on Capital Employed data on file, last reported at 36.47% in Q1 2026.
- Quarterly Return on Capital Employed fell 713.0% year-over-year to 36.47% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 36.47% (down 713.0% YoY) and the FY2025 annual result came in at 31.27%, down 336.0% from the prior year.
- Return on Capital Employed slipped to 36.47% in Q1 2026, from 33.23% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 18.09% in Q1 2022 to a low of 36.47% in Q1 2026.
- A 5-year average of 27.73% and a median of 28.27% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed plunged 2173 bps — and 2025, when it soared 503 bps.
- Tracing TMCI's Return on Capital Employed over 5 years: stood at 27.33% in 2022, then advanced by 6 bps to 25.57% in 2023, then decreased by 21 bps to 30.92% in 2024, then declined by 7 bps to 33.23% in 2025, then fell by 10 bps to 36.47% in 2026.
- The last three Return on Capital Employed figures came in at 36.47% (Q1 2026), 33.23% (Q4 2025), and 30.16% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 12.08% |
| 10 | Treace Medical Concepts | 281.67 Mn | 236.05 Mn | 35.61 Mn | -38.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -38.08% |
| Mar 31, 2026 | -36.47% |
| Dec 31, 2025 | -33.23% |
| Sep 30, 2025 | -30.16% |
| Jun 30, 2025 | -29.16% |
| Mar 31, 2025 | -29.34% |
| Dec 31, 2024 | -30.92% |
| Sep 30, 2024 | -34.36% |
| Jun 30, 2024 | -34.19% |
| Mar 31, 2024 | -28.27% |
| Dec 31, 2023 | -25.57% |
| Sep 30, 2023 | -22.73% |
| Jun 30, 2023 | -18.98% |
| Mar 31, 2023 | -22.41% |
| Dec 31, 2022 | -27.33% |
| Sep 30, 2022 | -27.37% |
| Jun 30, 2022 | -22.86% |
| Mar 31, 2022 | -18.09% |
| Dec 31, 2021 | -13.65% |
| Sep 30, 2021 | -5.63% |